CEL-SCI Co. (NYSE:CVM) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC lowered its holdings in CEL-SCI Co. (NYSE:CVM) by 6.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 572,484 shares of the company’s stock after selling 40,377 shares during the period. Geode Capital Management LLC owned about 0.77% of CEL-SCI worth $229,000 at the end of the most recent quarter.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of CEL-SCI in a report on Wednesday. They issued a “sell” rating on the stock.

CEL-SCI Stock Performance

CVM opened at $0.25 on Friday. CEL-SCI Co. has a twelve month low of $0.18 and a twelve month high of $2.39. The stock has a market cap of $21.12 million, a PE ratio of -0.52 and a beta of 0.95. The business’s 50 day moving average is $0.27 and its 200-day moving average is $0.47. The company has a current ratio of 1.07, a quick ratio of 1.09 and a debt-to-equity ratio of 0.66.

CEL-SCI Company Profile

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical trials for the potential treatment of certain head and neck cancers.